Literature DB >> 20727391

A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions.

Dexi Lin1, Yanbin Huang.   

Abstract

The aim of this work was to develop a method which uses experimentally obtainable data to predict the complete phase diagram of drug-polymer solid dispersion systems, for the first time in literature. Felodipine-poly(acrylic acid) (PAA) solid dispersion was used as an example to illustrate the application of this method. Samples were prepared with different drug loading and analyzed using differential scanning calorimetry (DSC). Values of the drug-polymer interaction parameter χ(T(m)) were calculated from the drug crystal melting point depression data. Since χ is a function of temperature (χ∼1/T) according to the Flory-Huggins theory, the obtained χ-T relationship thus enabled calculation of the complete temperature-composition phase diagram of a drug-polymer solid dispersion system. In experiments, felodipine was shown to be immiscible with PAA in almost the whole range of drug content at room temperature. Two glass transition temperatures were observed, corresponding to almost pure felodipine and pure PAA, respectively, in consistent with the predicted phase behavior.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727391     DOI: 10.1016/j.ijpharm.2010.08.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

1.  A systematic approach to design and prepare solid dispersions of poorly water-soluble drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

2.  Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory.

Authors:  Krishna Bansal; Uttam Singh Baghel; Seema Thakral
Journal:  AAPS PharmSciTech       Date:  2015-06-20       Impact factor: 3.246

3.  Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.

Authors:  Conor Donnelly; Yiwei Tian; Catherine Potter; David S Jones; Gavin P Andrews
Journal:  Pharm Res       Date:  2014-07-30       Impact factor: 4.200

4.  Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.

Authors:  Sonu Dalsania; Jagadish Sharma; Bhushan Munjal; Arvind K Bansal
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

5.  Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.

Authors:  Shu Li; Yiwei Tian; David S Jones; Gavin P Andrews
Journal:  AAPS PharmSciTech       Date:  2016-01-04       Impact factor: 3.246

6.  Screening methodologies for the development of spray-dried amorphous solid dispersions.

Authors:  Íris Duarte; José Luís Santos; João F Pinto; Márcio Temtem
Journal:  Pharm Res       Date:  2014-08-19       Impact factor: 4.200

7.  Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).

Authors:  Zhiqing Hu; Pengchong Xu; Eman A Ashour; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2022-06-17       Impact factor: 3.246

8.  Use of Flory-Huggins Interaction Parameter and Contact Angle Values to Predict the Suitability of the Drug-Polymer System for the Production and Stability of Nanosuspensions.

Authors:  Rakesh K Patel; Sriramakamal Jonnalagadda; Pardeep K Gupta
Journal:  Pharm Res       Date:  2022-05-03       Impact factor: 4.200

9.  A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.

Authors:  Siyuan Huang; Kevin P O'Donnell; Justin M Keen; Mark A Rickard; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-09-04       Impact factor: 3.246

10.  Theoretical prediction of a phase diagram for solid dispersions.

Authors:  Bin Tian; Xiaoyan Wang; Yuanyuan Zhang; Keru Zhang; Yu Zhang; Xing Tang
Journal:  Pharm Res       Date:  2014-08-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.